Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2018-09-12 History
Report ID 583
Drug Identification Number 02308444
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN - TAZOBACTUM
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 2G 0.25G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 30 ML
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-09-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-11 English Compare
v2 2017-03-11 French Compare
v3 2018-09-10 English Compare
v4 2018-09-10 French Compare
v5 2018-09-11 English Compare
v6 2018-09-12 English Compare
v7 2018-09-12 French Compare

Showing 1 to 7 of 7